ERBB2 and neoplasm: Among the 10 studies that reported on prognostic factors for BM diagnosis [15, 17, 18, 21–23, 26, 29–31], the most commonly assessed prognostic factors included age, HR status, receipt of anti-HER2 therapy, and tumor grade.